Cagrilintide mimics the effects of amylin, targeting multiple receptors including the calcitonin receptor and receptor activity-modifying proteins (RAMPs)
Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms
Gold Medallion Vitamin B Complex + Liver Extract Solution for Injection
It has passed phase 1 and 2 clinical trials and is currently in phase 3 trials, with an expected launch in 2026 or 2027 if approved
The most common injection site for Vitamin B12 is at the Vastus Lateralis located at the middle of the thigh
doi: 10.1016/j.mrfmmm.2005.08.004